The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer

Brain metastases are usual in non-small-cell lung cancer (NSCLC) with poor prognosis and few available therapeutic options. This retrospective study aims to evaluate the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) against brain metastases from NSCLC harboring...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Bai, Hao, Xiong, Liwen, Han, Baohui
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5415007/
https://ncbi.nlm.nih.gov/pubmed/28490892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S129809
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items